The Canadian Association of Professionals in Regulatory Affairs (CAPRA) is an organization dedicated to providing its members with opportunities to enhance their professional development and maximize career opportunities. Whether you are a student, an entry-level associate or an experienced executive, a membership with CAPRA is a must.

We foster learning, networking and professional excellence of our members. We will build and strengthen relationships with governmental agencies, scientific experts and industry educators in order to create an affordable, professionally fulfilling and academically enriching environment for our members.

Learn More


Introduction to Regulatory Affairs and the Regulatory Affairs Profession



A listing on the CAPRA website is available to consulting companies whose primary focus is Regulatory Affairs, Clinical Research, Quality Control or Compliance (GCP, GLP, GMP) for pharmaceuticals, biologics, veterinary drugs, medical devices, cosmetics, over-the-counter products, or natural health products.

MISSISSAUGA, Ontario Propharmex Inc. 2018-01-30
Vancouver, British Columbia Worldwide BioMedEx Inc. 2018-01-30
Burlington, Ontario Lockhart Regulatory Services Inc. 2018-02-09
Montreal, Quebec SNC Lavalin Inc. 2018-02-01
Kitchener, Ontario NaturalSci Regulatory Consulting Corp 2018-01-30


Reach CAPRA members through the NOC (News of Course), or place an employment ad in our listings.



Available to CAPRA Members

Planning to place an employment advertisement through CAPRA/ACRP? Looking for a new career opportunity? If so, you have come to the right place! CAPRA now has over 900 members in the regulatory affairs field!

Job Seekers: Scroll through our most recent postings, your dream job maybe at your fingers tips!

Employers: Regulatory professionals are difficult to find. Win the competition for talent, by advertising in CAPRA. Our email employment notice service brings you access to hundreds of top class, experienced professionals. One of them may be just whom you are looking for!



Post-NOC Level III Change Updates

Post-NOC Level III Change Updates

A post-NOC change is any change made to a new drug that has received a notice of compliance (NOC) pursuant to C.08.004 of the Food and Drug Regulations.

Cybersecurity – Draft Guidance Document

Cybersecurity – Draft Guidance Document

Medical devices play a pivotal and ever increasing role in improving access to care for patients. Through data exchange with network environments, medical devices facilitate timely diagnoses and treatments and improve access to healthcare information.  The tradeoff is that that devices can become vulnerable to cyberattacks. 

Proposed Amendments to Regulations under the Ontario Drug Benefit Act and the Drug Interchangeability and Dispensing Fee Act

Proposed Amendments to Regulations under the Ontario Drug Benefit Act and the Drug Interchangeability and Dispensing Fee Act

The Ministry of Health & Long-Term Care recently announced proposed amendments to the regulatory scheme affecting private label drug products.